8:15–8:45 |
Introductions and Welcome
James Cavuoto, Editor and Publisher, Neurotech Reports
Peter Peumans, Ph.D., CTO, Health Technologies, imec
|
8:45–9:30 |
State of the European Neurotechnology Industry, 2025
James Cavuoto, Editor and Publisher, Neurotech Reports
Neurotech Business Report Editor James Cavuoto provides his insights and observations on the state of the European neurotechnology industry. He surveys changes in the competitive landscape that have occurred over the years, the most significant events of the last year, and challenges confronting the industry in years ahead. |
9:30-10:15 |
Keynote Address
Tim Denison, Ph.D., FREng. Co-Founder, Amber Therapeutics |
10:15–10:45 |
Coffee Break |
10:45–11:30 |
In the Periphery
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Guy Siman, Co-founder and COO, Sensars
Holger Witkowski, Ph.D., Managing Director, Europe, Mainstay Medical
In this session, we'll look at new vendors and new applications of peripheral nerve stimulation systems. |
11:30-12:15 |
Entrepreneur Panel I
James Cavuoto, Editor, Neurotech Reports, Moderator
Charles Nolet, CEO, Synergia Medical
Laura Johnson, Ph.D., Co-founder and CEO, BrainScape Medical
Nader Yaghoubi, Co-founder and CEO, PathMaker Neurosystems, Inc.
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
12:15–13:30 |
Luncheon |
13:30-14:15 |
Crossing the Pond Bidirectionally
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Brian Highley, CEO, Cirtec Medical
Thorsten Gottsche, Ph.D., CTO, Osypka
In this session, we'll look at key issues facing European neurotech vendors seeking to market products in the U.S. and North American vendors seeking to market products in Europe. These include regulatory, reimbursement, and privacy/security concerns.
|
14:15-15:00 |
Neurotechnology at imec
Barun Dutta, Chief Scientist and Fellow, imec
Imec technology leaders offer an overview of their capabilites and facilities.
|
15:00-15:30 |
Refreshment Break |
15:30-16:15 |
BCI Leaders of Europe
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Nicolas Vachicouras, Ph.D., Co-founder and CEO, Neurosoft Bioelectronics
Carolina Aguilar, CEO and Co-Founder, INBRAIN Neuroelectronics
Rotem Koppel, Ph.D., CEO, Ability Neurotech
JoJo Platt moderates a panel with some of Europe's leading commercial firms pursuing the market for brain-computer interfaces.
|
16:30-17:30 |
Lab and Cleanroom Tours
|
17:30–20:00 |
Networking Reception at the Faculty Club
Closing remarks by Paru Deshpande, Ph.D., Vice President, R&D, Health Sector, imec
|
8:30–8:45 |
Introductions and Welcome |
8:45–9:30 |
Venture Capital Investment
James Cavuoto, Editor, Neurotech Reports, Moderator
Diana Saraceni, Co-founder and Managing Partner, Panakes Partners
Frank Bulens, Ph.D., Partner, imec Xpand
Josh Schulman, Ph.D., Chief Scientist, Corundum Neuroscience
Neurotech Business Report Editor James Cavuoto moderates a panel with leading venture capital firms active in Europe that fund neurotechnology ventures.
|
9:30-10:15 |
The Business of Neuromodulation
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Lothar Krinke, Ph.D., CEO, Adraxe Corp.
Frank Desiere, Ph.D., CEO CorTec
Lorenzo Rossi, CEO, Newronika
Jeremy Koff reviews key elements of launching a commercial neurotech firm, such as financial modeling, establishing valuations, selecting suppliers, and managing competition.
|
10:15–10:45 |
Coffee Break |
10:45–11:30 |
Inside, Outside, and Through
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Ana Maiques, CEO, Neuroelectrics
Tracy Laabs, Ph.D., Chief Development Officer, Wyss Center for Bio and Neuro
Julien Camisani, Vice President of Engineering, ONWARD Medical
In this session, we examine the tradeoff between implantable and noninvasive neuromodulation devices, including capitalization, regulatory, and competitive issues. |
11:30-12:15 |
Entrepreneur Panel II
James Cavuoto, Editor, Neurotech Reports, Moderator
Luca Ravagnan, CEO and Co-Founder, WISE SpA
George Chatzipirpiridis, Ph.D., Co-founder and COO, Magnes AG
Hubert Martens, Ph.D., CEO, Salvia BioElectronics
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
12:15–13:30 |
Luncheon |
13:30–14:15 |
Bioelectronic Medicine Applications
Victor Pikov, Contributing Editor, Neurotech Reports, Moderator
Robert Spoelgen, Ph.D., Vice-President, Merck Healthcare KGaA
Arun Sridhar, Ph.D., Co-Founder, Venture Builder
Jiande Chen, Ph.D., Professor, University of Michigan
In this session, we look at applications of neuromodulation beyond the central nervous system, including therapies for treating systemic and end-organ disorders. |
14:15-15:00 |
Exploring Peripheral Nerve Stimulation at imec
In this session, imec executives describe their capabilites with peripheral nerve stimulation systems, including ASICs and alternative stimulation methods.
|
15:00-15:30 |
Refreshment Break |
15:30-16:15 |
Entrepreneur Panel III
Jeremy Koff, senior consulting editor, Neurotech Reports, Moderator
Karl Stoklosa, CEO, Precisis GmbH
Frederik Ceyssens, Ph.D., Co-founder and CEO, ReVision Implant
Fabio Bio, Ph.D., CTO, Corticale,
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
16:15-17:15 |
Closing Remarks
|
|
|